Jennifer L. Gibson
The goal of this program is to help advanced practice nurses (nurse practitioners and clinical nurse specialists) fulfill the American Nurses Credentialing Center 25-contact hour pharmacotherapeutics requirement for certification. After studying the information presented here, you will be able to:
Suzanne Albrecht, MS, PharmD; Paul Arnstein, RN, MS, PhD, FAAN; Jane Dimmitt Champion, FNP, MSN, PhD, DNP, AH-PMH-CNS, FAAN; Kim Curry, ARNP, PhD; Heidi M. Dishneau, ARNP, MSN, AOCNP; Regina M. Fink, RN, PhD, AOCN, FAAN; Peggy Hasenauer, RN, MS; Annette Kelly, ARNP, MSN, PhD; Lenore C. Magrum, CRNP, MSN, AOCN; Cynthia H. McGee, ANP-BC, MSN CCRN; Cindy Parsons, ARNP, DNP, FAANP, BC; Susanne J. Pavlovich-Danis, RN, MSN, ARNP-C, CDE, CRRN; Kristine Anne Scordo, ACNP-BC, PhD, FAANP; Kim Strelczyk, RN, MSN, APRN, CIC; Anna Ver Hage, RN, CCRN, CNRN
Paul Arnstein, PhD, RN, FAAN, has disclosed that he receives consulting fees as a member of the clinical advisory board and consultant panels for AstraZeneca, Jannsen, Purdue, Hospira, and Mallinckrodt.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.